DF
HZNP

Donoghue Forlines’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Donoghue Forlines’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,260
Closed -$264K – 280
2022
Q3 		$264K Sell
4,260
-4,284
-50% -$265K 0.1% 186
2022
Q2 		$681K Buy
+8,544
New +$681K 0.18% 141